Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamitsu Inoue

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Urology|October 22, 2008
Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancerNorihiko Tsuchiya, Takamitsu Inoue, Shintaro Narita, et al.
Urology|November 11, 2006
Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tractTakeshi Yuasa, Norihiko Tsuchiya, Shintaro Narita, et al.
Urologia Internationalis|September 16, 2009
Cystoprostatectomy as a treatment of prostate cancer involving the bladder neckTeruaki Kumazawa, Norihiko Tsuchiya, Mitsuru Saito, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 31, 2015
Clinical benefits of tubeless umbilical cutaneous ureterostomyKazuyuki Numakura, Norihiko Tsuchiya, Makoto Takahashi, et al.
Cancer Biology & Therapy|February 8, 2024
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinomaKazuyuki Numakura, Ryoma Igarashi, Makoto Takahashi, et al.
International Journal of Clinical Oncology|August 12, 2023
Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022Hiroyuki Nishiyama, Takamitsu Inoue, Yuichi Koizumi, et al.
International Cancer Conference Journal|April 8, 2020
A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacementYoshinori Matsuda, Takamitsu Inoue, Atsushi Maeno, et al.
Transplant Immunology|September 8, 2020
Treg expansion with trichostatin A ameliorates kidney ischemia/reperfusion injury in mice by suppressing the expression of costimulatory moleculesRyohei Yamamoto, Mitsuru Saito, Takuro Saito, et al.
Journal of Endourology|April 12, 2012
Comparison of the clinical outcome and systemic inflammatory marker levels between retroperitoneal and transperitoneal laparoscopic donor nephrectomyMitsuru Saito, Norihiko Tsuchiya, Shintaro Narita, et al.
International Journal of Clinical Oncology|June 28, 2011
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancerShintaro Narita, Norihiko Tsuchiya, Takeshi Yuasa, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Urology|October 22, 2008
Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancerNorihiko Tsuchiya, Takamitsu Inoue, Shintaro Narita, et al.
Urology|November 11, 2006
Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tractTakeshi Yuasa, Norihiko Tsuchiya, Shintaro Narita, et al.
Urologia Internationalis|September 16, 2009
Cystoprostatectomy as a treatment of prostate cancer involving the bladder neckTeruaki Kumazawa, Norihiko Tsuchiya, Mitsuru Saito, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 31, 2015
Clinical benefits of tubeless umbilical cutaneous ureterostomyKazuyuki Numakura, Norihiko Tsuchiya, Makoto Takahashi, et al.
Cancer Biology & Therapy|February 8, 2024
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinomaKazuyuki Numakura, Ryoma Igarashi, Makoto Takahashi, et al.
International Journal of Clinical Oncology|August 12, 2023
Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022Hiroyuki Nishiyama, Takamitsu Inoue, Yuichi Koizumi, et al.
International Cancer Conference Journal|April 8, 2020
A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacementYoshinori Matsuda, Takamitsu Inoue, Atsushi Maeno, et al.
Transplant Immunology|September 8, 2020
Treg expansion with trichostatin A ameliorates kidney ischemia/reperfusion injury in mice by suppressing the expression of costimulatory moleculesRyohei Yamamoto, Mitsuru Saito, Takuro Saito, et al.
Journal of Endourology|April 12, 2012
Comparison of the clinical outcome and systemic inflammatory marker levels between retroperitoneal and transperitoneal laparoscopic donor nephrectomyMitsuru Saito, Norihiko Tsuchiya, Shintaro Narita, et al.
International Journal of Clinical Oncology|June 28, 2011
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancerShintaro Narita, Norihiko Tsuchiya, Takeshi Yuasa, et al.
Pageof 19